Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Asset Utilization Ratio: 2014-2020

Historic Asset Utilization Ratio for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to -0.04.

  • Larimar Therapeutics' Asset Utilization Ratio fell 137.44% to -0.04 in Q1 2020 from the same period last year, while for Mar 2020 it was -0.04, marking a year-over-year decrease of 137.44%. This contributed to the annual value of -0.03 for FY2019, which is 66.56% down from last year.
  • As of Q1 2020, Larimar Therapeutics' Asset Utilization Ratio stood at -0.04, which was down 10.31% from -0.04 recorded in Q4 2019.
  • Over the past 5 years, Larimar Therapeutics' Asset Utilization Ratio peaked at -0.00 during Q4 2017, and registered a low of -0.04 during Q1 2020.
  • For the 3-year period, Larimar Therapeutics' Asset Utilization Ratio averaged around -0.02, with its median value being -0.02 (2019).
  • In the last 5 years, Larimar Therapeutics' Asset Utilization Ratio soared by 57.59% in 2017 and then crashed by 814.84% in 2018.
  • Larimar Therapeutics' Asset Utilization Ratio (Quarterly) stood at -0.00 in 2016, then surged by 57.59% to -0.00 in 2017, then crashed by 814.84% to -0.01 in 2018, then tumbled by 140.66% to -0.04 in 2019, then crashed by 137.44% to -0.04 in 2020.
  • Its Asset Utilization Ratio stands at -0.04 for Q1 2020, versus -0.04 for Q4 2019 and -0.02 for Q3 2019.